Patient
SITE002-0171
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE002 (USA) (Dr. Nolan)
consented 2026-03-26
Adverse events
2
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-09-12
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-08 (study day 160); relationship: NOT RELATED
severe
serious
assessed
2026-06-09
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-03 (study day 65); relationship: NOT RELATED; serious criteria: hospitalization
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.